MRNA CFO converts 1,453 RSUs; 703 shares withheld at $28.37
Rhea-AI Filing Summary
Moderna, Inc. (MRNA) Chief Financial Officer converted 1,453 restricted stock units into common stock on 10/03/2025, increasing direct holdings to 18,962 shares. On the same date, 703 shares were withheld to cover tax obligations at an effective price of $28.37, leaving total direct beneficial ownership of 18,259 shares after the withholding. The RSUs convert one-for-one and follow a vesting schedule that began with a 25% tranche vesting on 10/05/2023, with the remainder vesting in twelve equal quarterly installments. The filing was signed by an attorney-in-fact on 10/06/2025.
Positive
- 1,453 RSUs vested, converting to common stock and increasing direct ownership
- Withholding for taxes used to satisfy obligations (703 shares), avoiding an open-market sale
Negative
- 703 shares withheld reduced reported post-transaction beneficial ownership to 18,259 shares
- Ongoing quarterly vesting will continue to increase the share count over the next 12 quarters, causing potential dilution
Insights
Insider vested RSUs and tax-withholding sale altered reported beneficial ownership.
The conversion of 1,453 restricted stock units into common shares increases direct ownership to 18,962 before withholding, reflecting scheduled compensation vesting under the grant that began vesting with a 25% tranche on 10/05/2023.
The withholding of 703 shares at an effective price of $28.37 reduced the post-transaction stake to 18,259 shares; this is a routine tax-withholding method rather than an open-market sale. Monitor remaining scheduled quarterly vesting over the next year for additional share issuances that will further affect dilution and insider ownership metrics.
Reported transactions are routine compensation events with limited immediate market impact.
The transactions consist of an RSU conversion (code M) and share withholding for taxes (code F), which are standard forms of settling employee equity awards and do not indicate discretionary cash sales by the officer.
Investor-relevant items to note are the 18,259 shares reported as beneficially owned after the transactions and the ongoing quarterly vesting schedule that will release more shares over the next 12 quarters, which could modestly affect share count and insider alignment with shareholder interests.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Restricted Stock Units | 1,453 | $0.00 | -- |
| Exercise | Common Stock | 1,453 | $0.00 | -- |
| Tax Withholding | Common Stock | 703 | $28.37 | $20K |
Footnotes (1)
- Restricted stock units convert into common stock on a one-for-one basis. Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. 25% of the shares subject to this restricted stock unit award vested on October 5, 2023 with the remainder vesting in twelve (12) equal quarterly installments thereafter.
